Platform development concentrated on:
• Automating import of data collected by other applications
• Immediacy and attractiveness of outputs
• Enhanced features to support multilingual and multi-regional implementations
• Event-based analytics
• Integration with specialist statistical packages
The result is that key areas of the system operate as one highly attractive interactive dashboard where users can select combinations of filters and view their impact on any selected set of insights whilst changes in cohort composition are automatically tracked and visualised and end users notified. Collaboration facilities enable ‘snapshots’ of results and ‘chat’; international use and localisation are fully supported, including a new ‘culture’ feature that allows application of terminology down to individual user level.
At the back end the application incorporates a vastly simplified AutoETL feature that massively accelerates loading of data into the database. New features such as multi-tenancy support cloud-based implementations.
The platform has been externally validated to confirm:
• Accuracy of results
• Auditability of analysis traces
• Security of source data
Commercialisation:
All 4 evaluation sites were sufficiently enthusiastic about the platform to go to contract to continue using it once the project ended. White papers from 3 evaluators were produced and published on the Imosphere website: Karolinska Institutet, University of Limerick and NCMH, Cardiff.
The company has been renamed and rebranded to reinforce an image as a leading edge technology provider ‘Imosphere’ (Imosphere= ‘i’ for Information +’mosphere’ for ‘atmosphere’ i.e. cloud-based information). New company websites went live in Europe and the USA (www.imosphere.co.uk and www.imosphere.com); our digital presence on platforms such as LinkedIn has grown substantially. Demonstration videos are available on YouTube eg
https://youtu.be/MrZ0hhyKDVU(odnośnik otworzy się w nowym oknie). Over25 conferences were attended, including 7 in the USA and 3 in Europe alongside dozens of webinars and workshops which resulted in major enhancement of the company’s profile in the marketplace.
A comprehensive product development and commercial strategy has been produced. We have actively engaged with 20+ prospective channel partners in Europe, UK, USA and Middle East leading to commercial agreements, either finalised or in process.
IP protection and freedom to operate was enhanced by the granting of 2 further patents, with several others in process, and registration of several new trademarks.